GlassScriptPhysician profile
Yoon Sin Kim
NPI 1235150764
$1,645.63
in general payments reported to CMS, 2019-2025
14 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.44 · 2024: $487 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.20 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $314.98 | 2025 | Tremfya, Simponi Aria |
| Lilly USA, LLC | $233.29 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $229.65 | 2025 | |
| Organon LLC | $167.38 | 2024-2025 | |
| Amgen INC. | $154.73 | 2024-2025 | Krystexxa, Otezla |
| Antares Pharma, INC. | $124.99 | 2025 | Xyosted |
| Journey Medical Corporation | $114.11 | 2025 | |
| Zimmer Biomet Holdings, INC. | $84.65 | 2024 | Sternalock 360 System, Sternalock Blu System |
| Ucb, INC. | $74.74 | 2025 | Bimzelx |
| Botanix Sb INC | $49.92 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.56 | 2025 | Cabtreo |
| Regeneron Healthcare Solutions, INC. | $20.34 | 2025 | Dupixent |
| Inspire Medical Systems, INC. | $17.85 | 2025 | Inspire |
| Ferring Pharmaceuticals INC. | $15.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoon Sin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.